These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32622180)

  • 1. Prognostic prediction of carcinoma by a differential-regulatory-network-embedded deep neural network.
    Li J; Ping Y; Li H; Li H; Liu Y; Liu B; Wang Y
    Comput Biol Chem; 2020 Oct; 88():107317. PubMed ID: 32622180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opening up the blackbox: an interpretable deep neural network-based classifier for cell-type specific enhancer predictions.
    Kim SG; Theera-Ampornpunt N; Fang CH; Harwani M; Grama A; Chaterji S
    BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):54. PubMed ID: 27490187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning algorithm and deep neural networks identified a novel subtype in hepatocellular carcinoma.
    Zi Q; Cui H; Liang W; Chi Q
    Cancer Biomark; 2022; 35(3):305-320. PubMed ID: 36373311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying prognostic features by bottom-up approach and correlating to drug repositioning.
    Li W; Yu J; Lian B; Sun H; Li J; Zhang M; Li L; Li Y; Liu Q; Xie L
    PLoS One; 2015; 10(3):e0118672. PubMed ID: 25738841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
    Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
    BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network-based drug sensitivity prediction.
    Ahmed KT; Park S; Jiang Q; Yeu Y; Hwang T; Zhang W
    BMC Med Genomics; 2020 Dec; 13(Suppl 11):193. PubMed ID: 33371891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNet-DNN: Inferring New Drug-Disease Associations with Deep Neural Network Based on Heterogeneous Network Features.
    Liu H; Zhang W; Song Y; Deng L; Zhou S
    J Chem Inf Model; 2020 Apr; 60(4):2367-2376. PubMed ID: 32118415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating prior biological knowledge for network-based differential gene expression analysis using differentially weighted graphical LASSO.
    Zuo Y; Cui Y; Yu G; Li R; Ressom HW
    BMC Bioinformatics; 2017 Feb; 18(1):99. PubMed ID: 28187708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TopMarker: Computational screening biomarkers of hepatocellular carcinoma from transcriptome and interactome based on differential network topological parameters.
    Wang Y; Wang T; Cao Y; Qiao X; Han X; Liu ZP
    Comput Biol Chem; 2024 Oct; 112():108166. PubMed ID: 39111022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma.
    Long J; Chen P; Lin J; Bai Y; Yang X; Bian J; Lin Y; Wang D; Yang X; Zheng Y; Sang X; Zhao H
    Theranostics; 2019; 9(24):7251-7267. PubMed ID: 31695766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Neural Network-Based Prediction of the Risk of Advanced Colorectal Neoplasia.
    Min JK; Yang HJ; Kwak MS; Cho CW; Kim S; Ahn KS; Park SK; Cha JM; Park DI
    Gut Liver; 2021 Jan; 15(1):85-91. PubMed ID: 33376229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EP-DNN: A Deep Neural Network-Based Global Enhancer Prediction Algorithm.
    Kim SG; Harwani M; Grama A; Chaterji S
    Sci Rep; 2016 Dec; 6():38433. PubMed ID: 27929098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
    Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
    Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis.
    Hua S; Ji Z; Quan Y; Zhan M; Wang H; Li W; Li Y; He X; Lu L
    Aging (Albany NY); 2020 Mar; 12(6):5439-5468. PubMed ID: 32213663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNN-Dom: predicting protein domain boundary from sequence alone by deep neural network.
    Shi Q; Chen W; Huang S; Jin F; Dong Y; Wang Y; Xue Z
    Bioinformatics; 2019 Dec; 35(24):5128-5136. PubMed ID: 31197306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma.
    Liao LE; Hu DD; Zheng Y
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32784402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.